Berger Montague PC Investigating Claims on Behalf of Marex Group plc (NASDAQ: MRX) Investors After Class Action Filing
Berger Montague PC Investigating Claims on Behalf of Marex Group plc (NASDAQ: MRX) Investors After Class Action Filing |
| [13-October-2025] |
PHILADELPHIA, Oct. 13, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Marex Group plc (NASDAQ: MRX) ("Marex" or the "Company") on behalf of investors who purchased Marex shares during the period of May 16, 2024 through August 5, 2025 (the "Class Period").
Investor Deadline: Investors who purchased Marex securities during the Class Period may, no later than December 8, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE. Marex, headquartered in London, is a global financial services firm providing trading, clearing, and risk management solutions. According to the lawsuit, on August 5, 2025, NINGI Research published a report alleging that Marex engaged in a multi-year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask true risk exposure. The report detailed numerous multi-million-dollar discrepancies in intercompany receivables and loans across Marex's network of over 56 entities. Examples of these discrepancies included a fabricated $17 million receivable, a subsidiary with profits inflated by 150% before liquidation, and an asset valued at $14.9 million sold weeks later for just $2.5 million with no reported loss. The report also alleged nearly $1 billion in off-balance-sheet derivatives exposure concealed through a Marex-controlled fund in Luxembourg was used to generate non-cash trading profits and inflate operating cash flow by misclassifying structured note issuance as income. Following the issuance of this report, Marex's stock price fell $2.33, or 6.2%, closing at $35.31 on unusually heavy trading volume, causing investor losses. If you are a Marex investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865. About Berger Montague For more information or to discuss your rights, please contact:
SOURCE Berger Montague | ||
Company Codes: NASDAQ:MRX |
View original content to download multimedia:
